NEW YORK (GenomeWeb News) – Privately held Quantiscientifics today said that BioDot will co-market and sell its A2 MicroArray System.
The A2 system allows for multiplexing in a 96-well plate format. The system was initially developed at Beckman Coulter and enables multiplexing of antibodies, peptides, antigens, and biomarkers.
Irvine, Calif.-based Quantiscientifics said that key applications for the system include multiplex ELISAs for cytokine detection, allergy testing, autoimmune disease, vaccines, and biomarker validation.
BioDot, also based in Irvine, sells products for the research and diagnostics markets including biochips, biosensors, lateral flow immunoassays, and liquid despensers.
Financial and others terms of the agreement were not disclosed.